Advertisement
Advertisement

CMRX

CMRX logo

Chimerix Inc

2.76
USD
-0.05
-1.78%
Dec 18, 15:20 UTC -5
Open

Chimerix Inc Profile

About

Chimerix is a biopharmaceutical company which develop medicines for lives of patients facing deadly diseases. The Company's most advanced clinical-stage development program ONC201, is in development for H3 K27M-mutant glioma. Chimerix is based in DURHAM, N.C.

Info & Links

CEO

Michael T. Andriole

Headquarters

2505 MERIDIAN PARKWAY, SUITE 100
DURHAM, NC 27713, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

71

Employees

72

Chimerix Inc Statistics

Valuation Measures

Market Capitalization2

248.23M

Enterprise Value

224.59M

Enterprise Value/EBITDA(ttm)

-2.31

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

818.86

Price to Book(mrq)

1.95

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-139513.78%

Return on Equity(ttm)

-50.78%

Return on Invested Capital(ttm)

-52.11%

Return on Assets(ttm)

-44.94%

Income Statement

Revenue(ttm)

159.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

159.00K

EBITDA(ttm)3

-97.10M

Net Income Available to Common(ttm)

-83.59M

Diluted EPS(ttm)

-0.94

Share Statistics

Beta (5Y Monthly)

1.02

52-Week Change

181.49%

S&P 500 52-Week Change

25.85%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

89.94M

Dividend Yield

0.00%

Float4

78.15M

% Held by Insiders

13.10%

% Held by Institutions

45.42%

Balance Sheet

Total Cash(mrq)

136.23M

Total Cash Per Share(mrq)

1.51

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.33%

Quick Ratio(mrq)

6.33%

Book Value Per Share(mrq)

1.51

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.62

Free Cash Flow(ytd)

-55.83M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement